The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease

The aim of our study was to elucidate the characteristics and natural history of Japanese nonalcoholic fatty liver disease (NAFLD). Two hundred and forty-seven patients were diagnosed as having biopsy-proven NAFLD at Tokyo Women's Medical University or an affiliated hospital from 1990 to June 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology research 2005-10, Vol.33 (2), p.72-76
Hauptverfasser: Hashimoto, Etsuko, Yatsuji, Saturu, Kaneda, Hiroyuki, Yoshioka, Yoko, Taniai, Makiko, Tokushige, Katsutoshi, Shiratori, Keiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 2
container_start_page 72
container_title Hepatology research
container_volume 33
creator Hashimoto, Etsuko
Yatsuji, Saturu
Kaneda, Hiroyuki
Yoshioka, Yoko
Taniai, Makiko
Tokushige, Katsutoshi
Shiratori, Keiko
description The aim of our study was to elucidate the characteristics and natural history of Japanese nonalcoholic fatty liver disease (NAFLD). Two hundred and forty-seven patients were diagnosed as having biopsy-proven NAFLD at Tokyo Women's Medical University or an affiliated hospital from 1990 to June 2004. Biopsies were scored for the severity of steatosis, necro-inflammation, and fibrosis according to modified Brunt criteria. We assessed the clinicopathological features and natural history of NAFLD in patients stratified by the stage of their fibrosis. Univariate and multivariate logistic analyses were performed, and the diagnostic ability was assessed by the area under the receiver operating characteristic curve. Clinicopathological features: The median age of the patients was 53 years, with a range from 10 to 89 years. There were 130 males and 117 females. Histologically, 46 patients were classified as F3 (bridging fibrosis), and 43 patients had F4 (cirrhosis). Females and older patients were more common in the F3–4 patients. Most of the F3–4 patients showed mild elevation of transaminases with significant deterioration of liver function tests compared with F0–2 patients. Ten patients were simultaneously diagnosed as having cirrhotic NASH and hepatocellular carcinoma (HCC). Natural history: During follow-up (median 44 months) of the F3–4 patients, 10 patients developed liver-related morbidity and five patients developed HCC. In the F3–4 patients, the 5-year cumulative incidence of HCC was 20%. Eight patients died (two of liver failure, four of HCC and two of other carcinomas). Serum markers for detecting F3– 4: Serum hyaluronic acid levels can accurately evaluate NAFLD patients with F3–4. The most important consequence of NAFLD patients with advanced fibrosis was HCC. Regular screening for this complication is extremely important.
doi_str_mv 10.1016/j.hepres.2005.09.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734111967</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386634605002949</els_id><sourcerecordid>734111967</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-253bb5ebcb36d5fc8602d5115b4bad86e153739c065dc482037cc093cbf345d73</originalsourceid><addsrcrecordid>eNp9kE2LFDEQhoMo7of-A5HcPHWbdD66-yLIsrrKgpcVvIWkUk1n6Om0SWZl_r0ZZsCbpyqK962q9yHkHWctZ1x_3LUzbglz2zGmWja2jPUvyDUf-q5hQv56WXsx6EYLqa_ITc47xnjPOvmaXHHdMcF7eU3c04wUZpssFEwhlwCZ2tXT1ZZDsgud6yymI40T_W43u2JGutkScC2Z_gllpmtc7QJxjksAOtlSjnQJz5ioDxltxjfk1WSXjG8v9Zb8_HL_dPfQPP74-u3u82MDksvSdEo4p9CBE9qrCQbNOq84V0466weNXIlejMC08iCHGqAHYKMANwmpfC9uyYfz3i3F3wfMxexDBlyW-nQ8ZNMLyTkf9Ukpz0pIMeeEk9lS2Nt0NJyZE1yzM2e45gTXsNFUuNX2_nLg4Pbo_5kuNKvg01mANeZzwGQyVFCAPiSEYnwM_7_wF0O6jpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734111967</pqid></control><display><type>article</type><title>The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease</title><source>Alma/SFX Local Collection</source><creator>Hashimoto, Etsuko ; Yatsuji, Saturu ; Kaneda, Hiroyuki ; Yoshioka, Yoko ; Taniai, Makiko ; Tokushige, Katsutoshi ; Shiratori, Keiko</creator><creatorcontrib>Hashimoto, Etsuko ; Yatsuji, Saturu ; Kaneda, Hiroyuki ; Yoshioka, Yoko ; Taniai, Makiko ; Tokushige, Katsutoshi ; Shiratori, Keiko</creatorcontrib><description>The aim of our study was to elucidate the characteristics and natural history of Japanese nonalcoholic fatty liver disease (NAFLD). Two hundred and forty-seven patients were diagnosed as having biopsy-proven NAFLD at Tokyo Women's Medical University or an affiliated hospital from 1990 to June 2004. Biopsies were scored for the severity of steatosis, necro-inflammation, and fibrosis according to modified Brunt criteria. We assessed the clinicopathological features and natural history of NAFLD in patients stratified by the stage of their fibrosis. Univariate and multivariate logistic analyses were performed, and the diagnostic ability was assessed by the area under the receiver operating characteristic curve. Clinicopathological features: The median age of the patients was 53 years, with a range from 10 to 89 years. There were 130 males and 117 females. Histologically, 46 patients were classified as F3 (bridging fibrosis), and 43 patients had F4 (cirrhosis). Females and older patients were more common in the F3–4 patients. Most of the F3–4 patients showed mild elevation of transaminases with significant deterioration of liver function tests compared with F0–2 patients. Ten patients were simultaneously diagnosed as having cirrhotic NASH and hepatocellular carcinoma (HCC). Natural history: During follow-up (median 44 months) of the F3–4 patients, 10 patients developed liver-related morbidity and five patients developed HCC. In the F3–4 patients, the 5-year cumulative incidence of HCC was 20%. Eight patients died (two of liver failure, four of HCC and two of other carcinomas). Serum markers for detecting F3– 4: Serum hyaluronic acid levels can accurately evaluate NAFLD patients with F3–4. The most important consequence of NAFLD patients with advanced fibrosis was HCC. Regular screening for this complication is extremely important.</description><identifier>ISSN: 1386-6346</identifier><identifier>EISSN: 1872-034X</identifier><identifier>DOI: 10.1016/j.hepres.2005.09.007</identifier><identifier>PMID: 16203174</identifier><language>eng</language><publisher>Netherlands: Elsevier Ireland Ltd</publisher><subject>Hepatocellular carcinoma ; Liver cirrhosis ; Natural history ; Nonalcoholic fatty liver disease ; Nonalcoholic steatohepatitis</subject><ispartof>Hepatology research, 2005-10, Vol.33 (2), p.72-76</ispartof><rights>2005 Elsevier Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-253bb5ebcb36d5fc8602d5115b4bad86e153739c065dc482037cc093cbf345d73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16203174$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashimoto, Etsuko</creatorcontrib><creatorcontrib>Yatsuji, Saturu</creatorcontrib><creatorcontrib>Kaneda, Hiroyuki</creatorcontrib><creatorcontrib>Yoshioka, Yoko</creatorcontrib><creatorcontrib>Taniai, Makiko</creatorcontrib><creatorcontrib>Tokushige, Katsutoshi</creatorcontrib><creatorcontrib>Shiratori, Keiko</creatorcontrib><title>The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease</title><title>Hepatology research</title><addtitle>Hepatol Res</addtitle><description>The aim of our study was to elucidate the characteristics and natural history of Japanese nonalcoholic fatty liver disease (NAFLD). Two hundred and forty-seven patients were diagnosed as having biopsy-proven NAFLD at Tokyo Women's Medical University or an affiliated hospital from 1990 to June 2004. Biopsies were scored for the severity of steatosis, necro-inflammation, and fibrosis according to modified Brunt criteria. We assessed the clinicopathological features and natural history of NAFLD in patients stratified by the stage of their fibrosis. Univariate and multivariate logistic analyses were performed, and the diagnostic ability was assessed by the area under the receiver operating characteristic curve. Clinicopathological features: The median age of the patients was 53 years, with a range from 10 to 89 years. There were 130 males and 117 females. Histologically, 46 patients were classified as F3 (bridging fibrosis), and 43 patients had F4 (cirrhosis). Females and older patients were more common in the F3–4 patients. Most of the F3–4 patients showed mild elevation of transaminases with significant deterioration of liver function tests compared with F0–2 patients. Ten patients were simultaneously diagnosed as having cirrhotic NASH and hepatocellular carcinoma (HCC). Natural history: During follow-up (median 44 months) of the F3–4 patients, 10 patients developed liver-related morbidity and five patients developed HCC. In the F3–4 patients, the 5-year cumulative incidence of HCC was 20%. Eight patients died (two of liver failure, four of HCC and two of other carcinomas). Serum markers for detecting F3– 4: Serum hyaluronic acid levels can accurately evaluate NAFLD patients with F3–4. The most important consequence of NAFLD patients with advanced fibrosis was HCC. Regular screening for this complication is extremely important.</description><subject>Hepatocellular carcinoma</subject><subject>Liver cirrhosis</subject><subject>Natural history</subject><subject>Nonalcoholic fatty liver disease</subject><subject>Nonalcoholic steatohepatitis</subject><issn>1386-6346</issn><issn>1872-034X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kE2LFDEQhoMo7of-A5HcPHWbdD66-yLIsrrKgpcVvIWkUk1n6Om0SWZl_r0ZZsCbpyqK962q9yHkHWctZ1x_3LUzbglz2zGmWja2jPUvyDUf-q5hQv56WXsx6EYLqa_ITc47xnjPOvmaXHHdMcF7eU3c04wUZpssFEwhlwCZ2tXT1ZZDsgud6yymI40T_W43u2JGutkScC2Z_gllpmtc7QJxjksAOtlSjnQJz5ioDxltxjfk1WSXjG8v9Zb8_HL_dPfQPP74-u3u82MDksvSdEo4p9CBE9qrCQbNOq84V0466weNXIlejMC08iCHGqAHYKMANwmpfC9uyYfz3i3F3wfMxexDBlyW-nQ8ZNMLyTkf9Ukpz0pIMeeEk9lS2Nt0NJyZE1yzM2e45gTXsNFUuNX2_nLg4Pbo_5kuNKvg01mANeZzwGQyVFCAPiSEYnwM_7_wF0O6jpA</recordid><startdate>20051001</startdate><enddate>20051001</enddate><creator>Hashimoto, Etsuko</creator><creator>Yatsuji, Saturu</creator><creator>Kaneda, Hiroyuki</creator><creator>Yoshioka, Yoko</creator><creator>Taniai, Makiko</creator><creator>Tokushige, Katsutoshi</creator><creator>Shiratori, Keiko</creator><general>Elsevier Ireland Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051001</creationdate><title>The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease</title><author>Hashimoto, Etsuko ; Yatsuji, Saturu ; Kaneda, Hiroyuki ; Yoshioka, Yoko ; Taniai, Makiko ; Tokushige, Katsutoshi ; Shiratori, Keiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-253bb5ebcb36d5fc8602d5115b4bad86e153739c065dc482037cc093cbf345d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Hepatocellular carcinoma</topic><topic>Liver cirrhosis</topic><topic>Natural history</topic><topic>Nonalcoholic fatty liver disease</topic><topic>Nonalcoholic steatohepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashimoto, Etsuko</creatorcontrib><creatorcontrib>Yatsuji, Saturu</creatorcontrib><creatorcontrib>Kaneda, Hiroyuki</creatorcontrib><creatorcontrib>Yoshioka, Yoko</creatorcontrib><creatorcontrib>Taniai, Makiko</creatorcontrib><creatorcontrib>Tokushige, Katsutoshi</creatorcontrib><creatorcontrib>Shiratori, Keiko</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashimoto, Etsuko</au><au>Yatsuji, Saturu</au><au>Kaneda, Hiroyuki</au><au>Yoshioka, Yoko</au><au>Taniai, Makiko</au><au>Tokushige, Katsutoshi</au><au>Shiratori, Keiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease</atitle><jtitle>Hepatology research</jtitle><addtitle>Hepatol Res</addtitle><date>2005-10-01</date><risdate>2005</risdate><volume>33</volume><issue>2</issue><spage>72</spage><epage>76</epage><pages>72-76</pages><issn>1386-6346</issn><eissn>1872-034X</eissn><abstract>The aim of our study was to elucidate the characteristics and natural history of Japanese nonalcoholic fatty liver disease (NAFLD). Two hundred and forty-seven patients were diagnosed as having biopsy-proven NAFLD at Tokyo Women's Medical University or an affiliated hospital from 1990 to June 2004. Biopsies were scored for the severity of steatosis, necro-inflammation, and fibrosis according to modified Brunt criteria. We assessed the clinicopathological features and natural history of NAFLD in patients stratified by the stage of their fibrosis. Univariate and multivariate logistic analyses were performed, and the diagnostic ability was assessed by the area under the receiver operating characteristic curve. Clinicopathological features: The median age of the patients was 53 years, with a range from 10 to 89 years. There were 130 males and 117 females. Histologically, 46 patients were classified as F3 (bridging fibrosis), and 43 patients had F4 (cirrhosis). Females and older patients were more common in the F3–4 patients. Most of the F3–4 patients showed mild elevation of transaminases with significant deterioration of liver function tests compared with F0–2 patients. Ten patients were simultaneously diagnosed as having cirrhotic NASH and hepatocellular carcinoma (HCC). Natural history: During follow-up (median 44 months) of the F3–4 patients, 10 patients developed liver-related morbidity and five patients developed HCC. In the F3–4 patients, the 5-year cumulative incidence of HCC was 20%. Eight patients died (two of liver failure, four of HCC and two of other carcinomas). Serum markers for detecting F3– 4: Serum hyaluronic acid levels can accurately evaluate NAFLD patients with F3–4. The most important consequence of NAFLD patients with advanced fibrosis was HCC. Regular screening for this complication is extremely important.</abstract><cop>Netherlands</cop><pub>Elsevier Ireland Ltd</pub><pmid>16203174</pmid><doi>10.1016/j.hepres.2005.09.007</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1386-6346
ispartof Hepatology research, 2005-10, Vol.33 (2), p.72-76
issn 1386-6346
1872-034X
language eng
recordid cdi_proquest_miscellaneous_734111967
source Alma/SFX Local Collection
subjects Hepatocellular carcinoma
Liver cirrhosis
Natural history
Nonalcoholic fatty liver disease
Nonalcoholic steatohepatitis
title The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T05%3A05%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20characteristics%20and%20natural%20history%20of%20Japanese%20patients%20with%20nonalcoholic%20fatty%20liver%20disease&rft.jtitle=Hepatology%20research&rft.au=Hashimoto,%20Etsuko&rft.date=2005-10-01&rft.volume=33&rft.issue=2&rft.spage=72&rft.epage=76&rft.pages=72-76&rft.issn=1386-6346&rft.eissn=1872-034X&rft_id=info:doi/10.1016/j.hepres.2005.09.007&rft_dat=%3Cproquest_cross%3E734111967%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734111967&rft_id=info:pmid/16203174&rft_els_id=S1386634605002949&rfr_iscdi=true